Caribou Biosciences (CRBU) Asset Utilization Ratio (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Asset Utilization Ratio data on file, last reported at 0.07 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.07, up 104.4% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07 (up 104.4% YoY), and the FY2025 annual result was 0.05, up 70.34% from the prior year.
• Asset Utilization Ratio grew to 0.07 in Q1 2026 per CRBU's latest filing, from 0.06 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.09 in Q3 2023 and troughed at 0.02 in Q1 2022.
• A 5-year average of 0.05 and a median of 0.04 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio surged 176.53% in 2023, then plunged 62.69% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2022, then jumped by 116.14% to 0.08 in 2023, then slumped by 60.78% to 0.03 in 2024, then soared by 98.27% to 0.06 in 2025, then increased by 14.63% to 0.07 in 2026.
• Business Quant data shows CRBU's Asset Utilization Ratio at 0.07 in Q1 2026, 0.06 in Q4 2025, and 0.04 in Q3 2025.